Bidil
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
  It has been noted that pharma research toward race-targeted medicine and it criticism is going on simultaneously over the…
In the United States, health disparities have been framed by categories of race. Racial health disparities have been documented…
According to the Food and Drug Administration [FDA], the goal of pharmacogenomics or “personalized medicine” is to tailor drug…
Dizziness and blurred vision in a 63-year-old patient can be traced to use of BiDil, a combination therapy given for the patient…
In a recent Health Affairs Web Exclusive, Pamela Sankar and Jonathan Kahn argue against the Food and Drug Administration's…
In this issue we present research, methodology, and commentary with important implications for policy as well as practice. Five…
Approval of 'race-based' drug is stimulating efforts to detect and predict true subgroups for drug response
A fixed-dose combination of 2 oral vasodilators for black patients with heart failure.
On 20 July 2004, it was reported that BiDil®, a drug aimed specifically at African Americans to treat heart failure, has proven…